Who owns the REVERE PHARMACEUTICALS trademark?

The REVERE PHARMACEUTICALS trademark is owned by Revere Pharmaceuticals, Inc..

What class is the REVERE PHARMACEUTICALS trademark registered in?

The REVERE PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REVERE PHARMACEUTICALS?

The USPTO serial number for REVERE PHARMACEUTICALS is 97861966.

What is the registration number for REVERE PHARMACEUTICALS?

REVERE PHARMACEUTICALS is registered under USPTO registration number 0.

REV

USPTO Trademark Record

ABANDONED

REVERE PHARMACEUTICALS

SN 97861966·Reg 0·Filed Mar 28, 2023

Owner Revere Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

REVERE PHARMACEUTICALS (Serial No. 97861966), Registration No. 0, is a abandoned US trademark filed on Mar 28, 2023 by Revere Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

REVERE PHARMACEUTICALS (Reg. #0) is an abandoned US trademark that was filed in 2023 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 28, 2023

SERIAL

97861966

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Revere Pharmaceuticals, Inc.

Entity

Corporation

State

Address

36 Orvis Road, Arlington, MA, 02474

Country

Attorney

NameJohn V. Hobgood, Esquire

Law firm

John V. Hobgood, Esquire WILMER CUTLER PICKERING HALE AND DORR LLP

Docket

2213253.125

Address

60 STATE STREET, BOSTON, MA 02109, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 28, 2023

Serial Number97861966

Registration No.0

Registration DateDec 31, 1969

Status DateOct 13, 2025

Published for OppositionJan 14, 2025

Mark TypeDesign with words

Attorney Docket2213253.125

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

19 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 13, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 13, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 14, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 14, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 08, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 19, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 13, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

SUSPENSION LETTER WRITTEN

Mar 13, 2024

SUSPENSION LETTER WRITTEN

CORRESPONDENCE E-MAILED

Mar 13, 2024

CORRESPONDENCE E-MAILED

NON-FINAL ACTION WRITTEN

Dec 23, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 23, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 23, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 21, 2023

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 21, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 20, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 31, 2023

NEW APPLICATION ENTERED

REVERE PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Revere Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John V. Hobgood, Esquire

Resources

Company